COMMUNIQUÉS West-GlobeNewswire

Xbrane Biopharma announces results of in-vivo study showing equivalent tolerability and pharmacokinetic profile of Xlucane compared to Lucentis®

04/10/2018 - 08:01

Press release 2018-10-04 In an in-vivo study involving 16 New Zeeland White rabbits Xlucane (ranibizumab (Lucentis ® ) biosimilar) demonstrated equivalent tolerability and pharmacokinetic profile in the serum and in the [...]

Rule 2.9 Announcement

04/10/2018 - 08:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 4 October 2018 [...]

Saniona Completes Planned Patient Recruitment for Second Part of Phase 2a Study for Tesomet in Prader-Willi Syndrome

04/10/2018 - 08:00

PRESS RELEASE October 4, 2018 Saniona, a leading biotech company within ion-channel research, today announced that it has completed the planned recruitment of adolescents for the second part of its Phase 2a study of [...]

Sandoz Healthcare Access Challenge (HACk) returns, seeking digital solutions to local healthcare access challenges

04/10/2018 - 07:16

Despite major advances in modern medicine, universal access to healthcare remains the largest unmet medical need Building on the inaugural Sandoz HACk, this year's competition expands to seek broader digital solutions [...]

Guardant Health Announces Pricing of Initial Public Offering

04/10/2018 - 01:38

REDWOOD CITY, Calif., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq:GH) today announced the pricing of its initial public offering of 12,500,000 shares of common stock at a public offering price of $19 [...]

Amedisys Extends Employment Agreement with CEO Paul Kusserow

03/10/2018 - 23:15

On Heels of Company Turnaround, Will Stay On For Three More Years BATON ROUGE, La., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), America’s leading independent home health, hospice and personal care [...]

Spring Bank Announces Inarigivir Data Presentations at AASLD Conference

03/10/2018 - 23:02

HOPKINTON, Mass., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, [...]

ICC Labs Obtains Interim Order for Arrangement With Aurora Cannabis

03/10/2018 - 23:00

VANCOUVER, British Columbia, Oct. 03, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (the Company or ICC Labs ) (TSX-V: ICC) is pleased to announce that it has obtained an interim order of the Supreme Court of British Columbia [...]

KemPharm to Host KOL Investor Event Focused on the ADHD Treatment Landscape

03/10/2018 - 22:41

Event to be Webcast Live on Thursday, October 11, 2018, at 8:30 a.m. ET CORALVILLE, Iowa, Oct. 03, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ:KMPH), a specialty pharmaceutical company focused on the discovery and [...]

BioPorto receives communication from FDA regarding The NGAL Test™

03/10/2018 - 22:40

October 3, 2018 Announcement no. 17 BioPorto receives communication from FDA regarding The NGAL Test™ BioPorto A/S (“BioPorto”) announces today that the company has received communication from the U.S. Food and Drug [...]

Retrophin to Highlight Fosmetpantotenate Program for PKAN at Upcoming Medical Congresses

03/10/2018 - 22:30

SAN DIEGO, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced that presentations highlighting the design of the ongoing pivotal Phase 3 FORT Study of fosmetpantotenate for the treatment of [...]

Acasti Pharma Announces Public Equity Offering

03/10/2018 - 22:23

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE U.S. LAVAL, Quebec, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (NASDAQ: ACST) (TSXV: ACST) (the “ Company ” or “ Acasti ”) is pleased [...]

Acasti Pharma Announces Proposed Underwritten Public Offering of Common Shares

03/10/2018 - 22:23

MONTRÉAL, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate [...]

Corvus Pharmaceuticals Announces Publication of Preclinical Results Highlighting Antitumor Activity of CPI-444 in Multiple Tumor Models both as Monotherapy and in Combination Studies

03/10/2018 - 22:15

As Combination, CPI-444 Showed Elimination of Tumors in 90% of Treated Mice and Restoration of Immune Response in Mice with Tumors Resistant to Therapy with anti-PD-1 and anti-CTLA-4 BURLINGAME, Calif., Oct. 03, 2018 ( [...]

Paratek Pharmaceuticals, Inc. to Host Investor Day on October 23, 2018

03/10/2018 - 22:05

BOSTON, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline [...]

Galapagos increases share capital through warrant exercises

03/10/2018 - 22:02

Mechelen, Belgium; 3 October 2018, 22.01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital increase arising from warrant exercises. Galapagos issued 135,485 new ordinary [...]

LaSanta Botanicals Announces Closing of $6.4 Million Financing

03/10/2018 - 21:23

CALGARY, Alberta, Oct. 03, 2018 (GLOBE NEWSWIRE) -- LaSanta Botanicals Ltd. (the “Company” or “LaSanta“) is pleased to announce that it has completed a non-brokered private placement offering of 10.7 million units (“ [...]

FDA Grants Orphan Drug Designation to Eidos Therapeutics’ Product Candidate, AG10, for Treatment of Transthyretin Amyloidosis

03/10/2018 - 20:35

SAN FRANCISCO, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Eidos Therapeutics, Inc. (Eidos) (Nasdaq:EIDX), a clinical stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by [...]

Esperite N.V. (ESP): Sale by Esperite of stake in Cryo-Save South Africa cancelled

03/10/2018 - 18:19

Amsterdam, The Netherlands - 3 October 2018 Esperite N.V. (Euronext: ESP, the "Company" or "Esperite") today announced that the sale agreement between Esperite and Go-Life Healthcare Limited ("Go-Life Healthcare") as [...]